Rob Byun currently serves as the Director of Financial Planning and Analysis at Arrowhead Pharmaceuticals, a position held since June 2023, where responsibilities include managing financial planning and analysis efforts and presenting budget variances to executive management. Previously, Rob held the role of Director of Finance at Twist Bioscience from November 2021 to June 2023, overseeing corporate development and strategic finance. Prior experience includes various roles at Amgen, including positions in Global Commercial FP&A, Product Analytics & Insights, Corporate Audit, and R&D FP&A from April 2011 to November 2021. Rob's career also features significant roles such as Senior Finance Manager at Paramount Pictures, Assistant Vice President at Merrill Lynch, and Financial Analyst at Bear Stearns Companies. Rob holds a Bachelor of Arts in Economics from the University of Chicago.
This person is not in any teams
This person is not in any offices